ScopusElsevier Scopus
Status
Active
Coverage
2015–2026
Source type
Journal
Open access
Yes
CiteScore
3.7
Best quartile
Q3 · 38th pctile
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Immunology and Allergy | 145 / 234 | 38th | Q3 |
| Immunology | 155 / 243 | 36th | Q3 |
ImmunoTargets and Therapy
ISSN 2253-1556
Publisher: Dove Medical Press Ltd
Scopus · Q3WoS · ESCIOpen Access
Is ImmunoTargets and Therapy indexed in Scopus? Yes — actively indexed in Scopus, coverage 2015–2026, best quartile Q3, CiteScore 3.7.
Is ImmunoTargets and Therapy in Web of Science? Yes — indexed in the Emerging Sources Citation Index.
Is ImmunoTargets and Therapy open access? Yes — it is an open-access journal, listed in DOAJ.
3.7
CiteScore 2025
Scopus
Q3
Best quartile
38th percentile
3
Indexed in
major indexes
Web of ScienceClarivate (SCIE/SSCI/AHCI/ESCI)
ABDCAustralian Business Deans Council 2025
Not listed in ABDC.
DOAJDirectory of Open Access Journals (live)
Checking DOAJ…
FT50Financial Times research list
Not listed in FT50.
UT DallasUTD top-100 business research
Not listed in UT Dallas.
ONOS · APC coveredOne Nation One Subscription (Govt of India)
Not in the ONOS APC-supported list.
Publishing in this journal is not centrally APC-funded under One Nation One Subscription.
Official sources & links
Related journals
Explore this journal in the interactive dashboard →
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.